Joslin Diabetes Center President and CEO Ranch C. Kimball to Step Down
BOSTON May 29, 2009 Joslin Diabetes Center, the worlds preeminent diabetes research and clinical care organization, announced today that its President and CEO Ranch C. Kimball will step down by the end of August. Kimball has been widely credited with improving the overall health and fiscal stability of the world-renowned organization.
Appointed in February 2007, Kimball, who previously served as Secretary of Economic Development for the Commonwealth of Massachusetts, was charged with expanding philanthropic giving to the Joslin, completing the sale of a Joslin-owned real estate parcel, improving Joslins fiscal stability and raising Joslins visibility in the community.
The Board of Trustees and I are pleased that Ranch achieved our strategic goals which, when combined, have put Joslin on solid footing for our future, said Kevin E. Conley, Chairman of the Board of Trustees. Under Kimballs leadership, philanthropic giving expanded dramatically with record giving in 2008, we completed the sale of a strategic real estate parcel, raising important revenue, Joslins financial position was solidified, and the Joslins visibility is significantly enhanced. We are extremely grateful to Ranch for his tremendous work to strengthen this vital institution.
Kimball also led a strategic planning process to identify a long-term vision for the Joslin. That process contributed to Kimballs decision to step down.
As part of our strategic planning process, it became clear that the next step for the Joslin is to further refine its scientific and medical agenda, said Kimball. I believe those goals are best achieved by a leader with a different background and experience. I am honored by the opportunity to have contributed to the important work of the Joslin.
Kimball will work with the Board of Trustees through August to support a search for his successor. Trustees and colleagues praised Kimball for his management ability and his commitment to the Centers health care mission.
Ranch was exactly the President and CEO we needed at the time, and he set the stage for the next phase of the Joslin, said John Brooks, Trustee and Finance Chair of the Center. His willingness to work alongside the Board while we restructure leadership around our medical and scientific programs is welcome, and we will miss him.
Ranch did a great job understanding the clinical and scientific issues in diabetes. Wed always see him walking through the halls in Clinic, asking doctors and nurses what was working, what wasnt, and about patient care, said Howard Wolpert, M.D., Director of the Insulin Pump program at Joslin and member of the Board of Trustees. He brought a level of passion and commitment to our clinical care model for diabetes treatment.
In addition to his service in the Romney administration, Kimball is one of Bostons most respected and well-known leaders. He serves on the boards of the Mass Business Roundtable, and Boston World Partnerships. He is Chair of the Board of Overseers of the Museum of Science, and Vice Chair of the Board of MassPort, where he also chairs the audit and finance committees. He was previously managing partner of private equity firm Kissinger McLarty Capital Group, and a long-time partner at Boston Consulting Group.
Courtesy of Joslin Diabetes Center
Surveys Find Adults with Type 2 Diabetes Are More Willing to Take Action to Achieve A1C Targets Quicker than Physicians and Other Medical Professionals Perceive
FDA Votes to Change Jardiance Label to Show Reduction in Heart-Related Deaths
Low Carb vs. High Carb II – My Diabetes Diet Battle Continued
Honey Mustard Turkey Salad Crunchy Chicken Pieces Beef Fajitas Fettuccine with Roasted Garlic, Onions, and Pepper Friendly Dog Salad Cranberry Coffee Cake Crunchy Chicken Bites with Thai Peanut Sauce Vegetable Letcho Zucchini Soup Strawberry Patch Nachos
Years before I was diagnosed with type 2 diabetes, The Other Half came out of a doctor's appointment with a diagnosis of "borderline diabetes" and an ADA exchange diet sheet. His health insurance agency followed up on the diagnosis with a glucometer and test strips. After a year or so of trying to follow the diet plan and test his glucose levels, things appeared to be back in "normal" range, and stood there until a couple of years after my own diagnosis. Shortly...